Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Pseudomonas aeruginosa infections of the eye, ear, urinary tract, gastrointestinal tract, and central nervous system

Souha S Kanj, MD
Daniel J Sexton, MD
Section Editor
Stephen B Calderwood, MD
Deputy Editor
Allyson Bloom, MD


Pseudomonas aeruginosa is one of the most commonly considered gram-negative aerobic bacilli in the differential diagnosis of a number of gram-negative infections. Consideration of this organism is important because it causes severe hospital-acquired infections, especially in immunocompromised hosts, is often antibiotic resistant, complicating the choice of therapy, and is associated with a high mortality rate.

The clinical manifestations, diagnosis, and treatment of P. aeruginosa eye, ear, urinary tract, gastrointestinal tract, and central nervous system infections will be reviewed here.

The general principles of antimicrobial treatment of infections caused by P. aeruginosa, including antibiotic options and decisions on combination therapy, are discussed in detail elsewhere. (See "Principles of antimicrobial therapy of Pseudomonas aeruginosa infections".)

The clinical manifestations and management of other P. aeruginosa infections and the epidemiology and pathogenesis of infection with this organism are also discussed separately.

(See "Epidemiology, microbiology, and pathogenesis of Pseudomonas aeruginosa infection".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Aug 5, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Smulders C, Brink H, Wanten G, et al. Conjunctival and corneal colonization by Pseudomonas aeruginosa in mechanically ventilated patients. A prospective study. Neth J Med 1999; 55:106.
  2. Meallet MA. Subpalpebral lavage antibiotic treatment for severe infectious scleritis and keratitis. Cornea 2006; 25:159.
  3. Chong R, Ayer CJ, Francis IC, et al. Adjunctive hyperbaric oxygen in pseudomonas keratitis. Br J Ophthalmol 2007; 91:560.
  4. McCormick C, Caballero A, Tang A, et al. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis. Curr Med Res Opin 2008; 24:1569.
  5. Bu P, Riske PS, Zaya NE, et al. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. J Ocul Pharmacol Ther 2007; 23:213.
  6. Cruciani M, Malena M, Amalfitano G, et al. Molecular epidemiology in a cluster of cases of postoperative Pseudomonas aeruginosa endophthalmitis. Clin Infect Dis 1998; 26:330.
  7. Eifrig CW, Scott IU, Flynn HW Jr, Miller D. Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology 2003; 110:1714.
  8. Clark WB, Brook I, Bianki D, Thompson DH. Microbiology of otitis externa. Otolaryngol Head Neck Surg 1997; 116:23.
  9. Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician 2012; 86:1055.
  10. Hawke M, Wong J, Krajden S. Clinical and microbiological features of otitis externa. J Otolaryngol 1984; 13:289.
  11. Roland PS, Parry DA, Stroman DW. Microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg 2005; 133:585.
  12. Jang CH, Park H, Cho YB, et al. The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study. Int J Pediatr Otorhinolaryngol 2009; 73:295.
  13. Cumberworth VL, Hogarth TB. Hazards of ear-piercing procedures which traverse cartilage: a report of Pseudomonas perichondritis and review of other complications. Br J Clin Pract 1990; 44:512.
  14. Warwick-Brown NP, Richards AE. Perichondritis of the ear following acupuncture. J Laryngol Otol 1986; 100:1177.
  15. Keene WE, Markum AC, Samadpour M. Outbreak of Pseudomonas aeruginosa infections caused by commercial piercing of upper ear cartilage. JAMA 2004; 291:981.
  16. Lee TC, Gold WL. Necrotizing Pseudomonas chondritis after piercing of the upper ear. CMAJ 2011; 183:819.
  17. Rowshan HH, Keith K, Baur D, Skidmore P. Pseudomonas aeruginosa infection of the auricular cartilage caused by "high ear piercing": a case report and review of the literature. J Oral Maxillofac Surg 2008; 66:543.
  18. Liu ZW, Chokkalingam P. Piercing associated perichondritis of the pinna: are we treating it correctly? J Laryngol Otol 2013; 127:505.
  19. Davidi E, Paz A, Duchman H, et al. Perichondritis of the auricle: analysis of 114 cases. Isr Med Assoc J 2011; 13:21.
  20. Noel SB, Scallan P, Meadors MC, et al. Treatment of Pseudomonas aeruginosa auricular perichondritis with oral ciprofloxacin. J Dermatol Surg Oncol 1989; 15:633.
  21. Suman E, Varghese S, Jose J. Gentamicin resistance in biofilm producing Pseudomonas aeruginosa causing catheter associated urinary tract infections. Indian J Med Sci 2005; 59:214.
  22. Yardy GW, Cox RA. An outbreak of Pseudomonas aeruginosa infection associated with contaminated urodynamic equipment. J Hosp Infect 2001; 47:60.
  23. Bilavsky E, Pfeffer I, Tarabeia J, et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa infection following urodynamic studies traced to contaminated transducer. J Hosp Infect 2013; 83:344.
  24. Peña C, Dominguez MA, Pujol M, et al. An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward. Clin Microbiol Infect 2003; 9:938.
  25. Boutiba-Ben Boubaker I, Boukadida J, Triki O, et al. [Outbreak of nosocomial urinary tract infections due to a multidrug resistant Pseudomonas aeruginosa]. Pathol Biol (Paris) 2003; 51:147.
  26. Stamey, TA. Rinary infections. Williams &Wilkins, Baltimore 1972. p.279.
  27. Carpenito G, Kurtz I. Green urine in a critically ill patient. Am J Kidney Dis 2002; 39:E20.
  28. Banovac K, Wade N, Gonzalez F, et al. Decreased incidence of urinary tract infections in patients with spinal cord injury: effect of methenamine. J Am Paraplegia Soc 1991; 14:52.
  29. Centers for Disease Control (CDC). Nosocomial infection and pseudoinfection from contaminated endoscopes and bronchoscopes--Wisconsin and Missouri. MMWR Morb Mortal Wkly Rep 1991; 40:675.
  30. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993; 118:117.
  31. Fraser TG, Reiner S, Malczynski M, et al. Multidrug-resistant Pseudomonas aeruginosa cholangitis after endoscopic retrograde cholangiopancreatography: failure of routine endoscope cultures to prevent an outbreak. Infect Control Hosp Epidemiol 2004; 25:856.
  32. Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis 1993; 17:484.
  33. Katz JA, Wagner ML, Gresik MV, et al. Typhlitis. An 18-year experience and postmortem review. Cancer 1990; 65:1041.
  34. Urbach DR, Rotstein OD. Typhlitis. Can J Surg 1999; 42:415.
  35. Altucci P, Abbate GF, Leonessa V, Alagia I. [Classification of acute bacterial enteropathies]. Minerva Med 1977; 68:2575.
  36. Chuang CH, Wang YH, Chang HJ, et al. Shanghai fever: a distinct Pseudomonas aeruginosa enteric disease. Gut 2014; 63:736.
  37. Cheng BC, Chang WN, Lu CH, et al. Bacterial meningitis in hemodialyzed patients. J Nephrol 2004; 17:236.
  38. Pomar V, Benito N, López-Contreras J, et al. Spontaneous gram-negative bacillary meningitis in adult patients: characteristics and outcome. BMC Infect Dis 2013; 13:451.
  39. Pollock S. Understanding liability insurance: the "tail" termination. Dent Manage 1989; 29:34.